Birdsong Health Literacy Center of Excellence Appoints Transformative Healthcare Leader Dr. Roni Christopher as Executive Director

March 12, 2025 4:55 PM

The Birdsong Health Literacy Center of Excellence (BHLCOE) is excited to announce the appointment of trailblazing healthcare innovator Dr. Roni Christopher as its new Executive Director. Dr. Christopher, celebrated for her exceptional leadership, bold vision, and passion for transformative community healthcare, will spearhead the Center's mission into a vibrant new phase of growth, innovation, and national impact.Dr. Christopher brings over two...

Read more

Monogram Technologies Reports Full Year 2024 Financial Results

March 12, 2025 4:01 PM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, has reported its financial and operational results for the fourth quarter and year ended December 31, 2024.Fourth Quarter 2024 and Subsequent Operational HighlightsCompleted all supplemental testing and submitted its formal response to the U.S. Food and Drug...

Read more

Closing Borders on American Tech: Healthcare IT's New International Reality, Black Book Global Poll

March 12, 2025 4:00 PM

A newly conducted ad hoc international survey of 543 global healthcare IT buyers and decision-makers outside the United States (achieving a statistical accuracy of approximately ±4,2% at a 95% confidence level) reveals a growing preference for non-U.S. electronic patient health record (EHR/EPR) providers. The findings presented are solely the result of gathered polling and survey responses from international healthcare IT stakeholders, without...

Read more

HonorBridge President & CEO Danielle Bumarch Recognized as a 2025 Woman in Business

March 12, 2025 12:00 PM

HonorBridge is proud to announce that its President & CEO, Danielle Bumarch, has been named a 2025 Woman in Business by the Triangle Business Journal. This prestigious award honors outstanding female leaders in the Triangle area who have demonstrated excellence in business and community service.Bumarch joins an elite group of 27 distinguished leaders across industries such as technology, law, health care, and hospitality. The Women in Business...

Read more

Arthritis Foundation Cycling Events Draw Celebrity Support in 2025

March 12, 2025 9:35 AM

The Arthritis Foundation proudly announces actor Nancy Travis, chef Biju Thomas and race car driver Natalie Decker as the 2025 Arthritis Foundation Cycling Experience Celebrity Ambassadors. Each will support the Foundation's inaugural Carolina Hills Classic Bike Tour, June 12-15, or the 25th anniversary California Coast Classic Bike Tour, September 6-13. As Ambassadors they will help raise awareness of the Tours and the Foundation - the leading...

Read more

PrestigePEO Announces the Strategic Acquisition of Concurrent HRO to Expand Market Presence and Enhance Service Delivery

March 12, 2025 9:30 AM

PrestigePEO, a leading Professional Employer Organization (PEO), has acquired Concurrent HRO, a Colorado-based PEO. The acquisition, PrestigePEO's fifth, expands PrestigePEO's national presence and enhances its ability to provide Midwest and Mountain region businesses with premium benefits, HR solutions, risk management services, and administrative support.With similar business models, strong leadership, and broker-friendly growth strategies,...

Read more

Cognixion Launches Clinical Trial for Late-Stage ALS to Deliver Conversation Level Communication with Adaptive AI-Driven Brain-Computer Interface

March 12, 2025 9:00 AM

Cognixion, a leading developer of noninvasive Brain-Computer Interface (BCI), Artificial Intelligence (AI) and Augmented Reality (AR) technology, today announced the launch of a clinical trial examining the company's integrated, wearable augmented reality and brain-computer interface (BCI) device, Axon-R, paired with their proprietary AI-powered application to help individuals with amyotrophic lateral sclerosis (ALS) communicate effectively. The...

Read more

OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

March 12, 2025 8:30 AM

CS Diagnostics Corp. (OTCQB:CSDX) (or "the company") is delighted to announce the appointment of Lachman Consultants Inc., Westbury, NY www.lachmanconsultants.com to provide its regulatory expertise and support in the company's effort to acquire FDA approval for its CS-Protect Hydrogel. CS-Protect Hydrogel is an organ spacer medical device that requires registration or approval from the respective governmental authorities, in particular the Food...

Read more

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

March 12, 2025 8:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-50 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on Friday, March 14, 2025, and Applied DNA common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market as of the commencement...

Read more

CTT Pharma's CEO Issues Letter to Shareholders

March 12, 2025 7:59 AM

TAMPA, FL / ACCESS Newswire / March 12, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH)Dear Shareholders,I wanted to issue this brief letter to share a few updates. To start, it's important to note that there are no delays with the NIH or NSF grants. These grants were filed in advance of the January 6th deadline and as a result we are expecting answers in May possibly April. I also received notification that the review process for these...

Read more

Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target

March 12, 2025 7:30 AM

On any given day, there are over 100,000 people in the U.S. alone waiting for an organ transplant. Of that group, approximately 17 will succumb to their illness each day without a transplant. That's why doctors and researchers have turned to non-human organs to make up for the shortfall. In March 2024 doctors performed the first ever transplant of a modified pig kidney into a living human. However, the rejection rate for non-human organs,...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Raises $3.6M in 3-year Notes from Existing Institutional Investor

March 12, 2025 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the previously-announced institutional investor has exercised its option to invest an additional $3.6M into the Company through the purchase of senior secured convertible notes, with a fixed conversion price at a 30% premium to the yesterday's closing, as well as plain-vanilla...

Read more

AI-Driven Bioz Badges Revolutionize Decision-Making for FiberCell Systems’ Customers

March 12, 2025 3:00 AM

Bioz, Inc., at the forefront of AI-powered citation management, is thrilled to highlight its ongoing partnership with FiberCell Systems, a pioneering provider of high-performance 3D cell culture technology. Through the integration of Bioz Badges on its website, FiberCell Systems is utilizing citation insights to boost researcher engagement, enhance product credibility, and improve sales conversions.Since implementing Bioz's most popular...

Read more

First Patient Enrolled in Cantargia's Leukemia Study with nadunolimab

March 12, 2025 2:50 AM

LUND, SE / ACCESS Newswire / March 12, 2025 / Cantargia (STO:CANTA)Open label study in forty AML and MDS patientsStudy financed by the US Department of DefenseCantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that the first subject has been enrolled in a study with patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). This phase 1b/2a study is an investigator-initiated clinical study and will investigate...

Read more

IRLAB Publishes Preclinical Data on mesdopetam in the Esteemed European Journal of Neuroscience

March 12, 2025 2:50 AM

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that preclinical data on mesdopetam has been published in the prestigious, peer-reviewed medical journal European Journal of Neuroscience, EJN. The data provide new insights into...

Read more

Official Announcement: Strategic Initiative Launched to Revolutionize Pharmaceutical Manufacturing and Strengthen Africa's Medicine Security

March 11, 2025 9:40 PM

In a landmark effort to transform Nigeria's pharmaceutical industry and reduce reliance on imported medicines, a coalition of pharmaceutical experts have highlighted a bold strategy to de-risk pharmaceutical resources, strengthen local production, and establish Nigeria as a pharmaceutical powerhouse in Africa.Led by Pharm. Otuto Amarauche Chukwu, Precious Azino Usuemerai, Dr. Cordia Peter Ogbeta, and Pharm. Olumide Ibikunle, this strategic...

Read more

DeepRx Inc. Appoints Mr. Wensheng Fan as CEO for the AI in Precision Oncology Company

March 11, 2025 9:20 PM

DeepRx Inc., a predictive analytics company advancing AI-driven solutions for precision oncology, is pleased to announce the appointment of Wensheng Fan as its new Chief Executive Officer.As CEO of DeepRx, Wensheng Fan will guide DeepRx in the commercialization of COLOXIS, an AI-powered chemotherapy drug-selection tool, which optimizes treatment for colorectal cancer patients.Wensheng Fan joins DeepRx as an accomplished technology executive and...

Read more

Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

March 11, 2025 7:00 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that further to its news release on February 18, 2025, through its wholly-owned U.S. subsidiary Medicure Pharma Inc., it has closed on the acquisition of 100% of Gateway Medical Pharmacy Inc....

Read more

Open Wound Research and Venture Medical Announce Collaboration to Advance Pressure Ulcer Research

March 11, 2025 6:45 PM

Open Wound Research and Venture Medical, LLC have entered into a collaborative research agreement to advance the study of pressure ulcer treatment. As part of this partnership, Venture Medical has acquired extensive pressure ulcer data from Open Wound Research to evaluate the efficacy of CAMPS in comparison to standard of care (SOC) treatments.Pressure ulcers, also known as pressure injuries or bedsores, remain a significant healthcare...

Read more

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

March 11, 2025 3:55 PM

Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today announced its financial results for its third quarter of fiscal 2025, ended January 31, 2025.Third Quarter and Recent Highlights:Total revenue increased 42% to $17.0 millionGross profit of $10.4 million; gross margin of 61%Net income of approximately $4.5 millionAdjusted EBITDA of $5.2...

Read more